Tilray Brands, Inc. announced that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom. Tilray Medical now offers the broadest portfolio of cannabis flower in the UK market, including a differentiated range of high THC products, cultivated at its EU-GMP- certified facility in Portugal.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | +6.98% | +0.55% | -20.00% |
Apr. 23 | TSX climbs as tech stocks power broader recovery | RE |
Apr. 11 | Tilray's Montauk Brewing Releases First Non-Alcoholic Brew | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.00% | 1.42B | |
+27.92% | 672B | |
+27.68% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.30% | 217B | |
+4.80% | 199B | |
-6.05% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- TLRY Stock
- News Tilray Brands, Inc.
- Tilray Medical Expands Portfolio of Medical Cannabis Products in the UK